These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9190256)

  • 1. [Use of fast-acting adaptogens and symptomatic means during evacuation of trauma victims by air transportation].
    Grechko AT; Glaznikov LA
    Aviakosm Ekolog Med; 1997; 31(2):47-9. PubMed ID: 9190256
    [No Abstract]   [Full Text] [Related]  

  • 2. [The enhancement of the adaptive resistance of wounded patients to the action of the factors in air transport evacuation].
    Grechko AT; Glaznikov LA; Butko DIu
    Voen Med Zh; 1996 Nov; 317(11):11-3. PubMed ID: 9036622
    [No Abstract]   [Full Text] [Related]  

  • 3. [Does treatment with piracetam in stroke patients with aphasia make sense?].
    Schmidtke K
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2636. PubMed ID: 12469280
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of piracetam on urea-induced myoclonus in rats].
    Nanri M; Yamamoto A; Matsuura N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 May; 20(2):45-50. PubMed ID: 11062861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative study of noopept and piracetam in the treatment of mild and moderate cognitive impairment in patients with organic brain diseases of vascular and traumatic origin].
    Neznamov GG; Teleshova ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):33-42. PubMed ID: 18697252
    [No Abstract]   [Full Text] [Related]  

  • 6. [The consequences of closed traumatic brain injury and piracetam efficacy in their treatment in adolescents].
    Zavadenko NN; Guzilova LS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):43-8. PubMed ID: 18427539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin.
    Neznamov GG; Teleshova ES
    Neurosci Behav Physiol; 2009 Mar; 39(3):311-21. PubMed ID: 19234797
    [No Abstract]   [Full Text] [Related]  

  • 8. Sequelae of closed craniocerebral trauma and the efficacy of piracetam in its treatment in adolescents.
    Zavadenko NN; Guzilova LS
    Neurosci Behav Physiol; 2009 May; 39(4):323-8. PubMed ID: 19340573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Piracetam as a corrector of long-term learning disorders caused by prenatal alcohol exposure: the significance of the length of therapy].
    Trofimov SS; Ostrovskaia RU; Smol'nikova NM; Kravchenko EV; Nemova EP; Voronina TA
    Biull Eksp Biol Med; 1996 Apr; 121(4):435-7. PubMed ID: 8829460
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinicoimmunological effects of piracetam and aevit in the course of duodenal ulcer patients' therapy].
    Balobanov VI; Vakhrushev SP; Velikosel'skaia LM
    Klin Med (Mosk); 1996; 74(7):56-7. PubMed ID: 8992120
    [No Abstract]   [Full Text] [Related]  

  • 11. [Increse in postradiation disorders of the vascular-tissue barriers in rabbits asd effected by "aeron"].
    Arlaschenko NI
    Radiobiologiia; 1981; 21(2):310-4. PubMed ID: 6972548
    [No Abstract]   [Full Text] [Related]  

  • 12. [A neuroprotective effect of the herbal drug neurofit in alcoholic intoxication].
    Dashinamzhilov ZhB; Lonshakova KS; Ubasheev IO; Nikolaev SM; Gulevich AA
    Patol Fiziol Eksp Ter; 2007; (4):27-9. PubMed ID: 18154085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of preparations from the nootropic group for treating memory disorders in chronic alcoholism].
    Shabanov PD; Grinenko AIa; Kalishevich SIu
    Klin Med (Mosk); 1988 Sep; 66(9):114-6. PubMed ID: 3204950
    [No Abstract]   [Full Text] [Related]  

  • 14. [Piracetam in combined pathogenetic therapy of recurrent duodenal ulcer].
    Tsimmerman IaS; Shchetkin DI
    Klin Med (Mosk); 2002; 80(1):48-53. PubMed ID: 11855320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [State of the hemostasis system and pathogenetic therapy of circulatory encephalopathy].
    Bekuzarova MR; Burd GS; Kolesnikova TI; Iasamanova AN; Kabanov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):35-8. PubMed ID: 11517473
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phenotropil in the treatment of vascular encephalopathy].
    Gustov AA; Smirnov AA; Korshunova IuA; Andrianova EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(3):52-3. PubMed ID: 16608112
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of the combined drug vinpotropil at early stages of cerebrovascular insufficiency].
    Zakharov VV; Lokshina AB; Stakhovskaia LV; Timerbaeva SL; Lagoda OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):76-8. PubMed ID: 18686371
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative evaluation of the neuroprotective activity of phenotropil and piracetam in laboratory animals with experimental cerebral ischemia].
    Tiurenkov IN; Bagmetov MN; Epishina VV
    Eksp Klin Farmakol; 2007; 70(2):24-9. PubMed ID: 17523446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piracetam--an old drug with novel properties?
    Winnicka K; Tomasiak M; Bielawska A
    Acta Pol Pharm; 2005; 62(5):405-9. PubMed ID: 16459490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The results of using lucetam in patients with moderate cognitive impairment of different genesis].
    Batysheva TT; Otcheskaia OV; Nesterova ON; Lisinker LN; Bobina LA; Ismailov AM; Shekkhirimov RK; Zhuravleva EIu; Kamchatnov PR; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):63-5. PubMed ID: 19255983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.